Serum midkine correlates with tumor progression and imatinib response in gastrointestinal stromal tumors

Tamina Rawnaq, Miriam Kunkel, Ronald Simon, Hilke Zander, Kai Bachmann, Guido Sauter, Jakob R. Izbicki & Jussuf T. Kaifi
Introduction: A previous study identified midkine (MK) expression in primary gastrointestinal stromal tumor (GIST) as a prognostic marker. The aim of the current study was to compare serum midkine (S-MK) concentrations of GIST patients with those of healthy controls and to determine if MK can serve [for full text, please go to the a.m. URL]